You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 565 Effect of non-overlapping mutations in BRAF, NRAS or NF1 on long-term survival after checkpoint inhibitor-based treatment for metastatic melanoma

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Checkpoint Blockade Therapy
565 Effect of non-overlapping mutations in BRAF, NRAS or NF1 on long-term survival after checkpoint inhibitor-based treatment for metastatic melanoma

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023130010
Dec 20237504
Jan 20242000
Feb 20241201
Mar 20241402
Apr 20242000
May 20241400
Jun 20241903
Jul 2024202
Aug 20241903
Sep 20242604
Oct 20241301
Nov 2024601
Dec 20241002
Jan 20251206
Feb 2025202
Mar 2025002
Apr 2025001
May 2025004
Jun 2025102
Total395050